Cargando…

Unmasking Intra-Tumoral Heterogeneity and Clonal Evolution in NF1-MPNST

Sarcomas are highly aggressive cancers that have a high propensity for metastasis, fail to respond to conventional therapies, and carry a poor 5-year survival rate. This is particularly true for patients with neurofibromatosis type 1 (NF1), in which 8%–13% of affected individuals will develop a mali...

Descripción completa

Detalles Bibliográficos
Autores principales:	Moon, Chang-In, Tompkins, William, Wang, Yuxi, Godec, Abigail, Zhang, Xiaochun, Pipkorn, Patrik, Miller, Christopher A., Dehner, Carina, Dahiya, Sonika, Hirbe, Angela C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7291009/ https://www.ncbi.nlm.nih.gov/pubmed/32369930 http://dx.doi.org/10.3390/genes11050499

Ejemplares similares

Chromosome 8 gain is associated with high-grade transformation in MPNST
por: Dehner, Carina, et al.
Publicado: (2021)

Aberrant ATRX protein expression is associated with poor overall survival in NF1-MPNST
por: Lu, Hsiang-Chih, et al.
Publicado: (2018)

Correction: Aberrant ATRX protein expression is associated with poor overall survival in NF1-MPNST
por: Lu, Hsiang-Chih, et al.
Publicado: (2021)

Whole exome sequencing reveals the maintained polyclonal nature from primary to metastatic malignant peripheral nerve sheath tumor in two patients with NF1
por: Godec, Abigail, et al.
Publicado: (2019)

Genomics of MPNST (GeM) Consortium: Rationale and Study Design for Multi-Omic Characterization of NF1-Associated and Sporadic MPNSTs
por: Miller, David T., et al.
Publicado: (2020)

NFB-01. FUNCTIONAL CHARACTERIZATION OF ATRX LOSS IN NF1-ASSOCIATED GLIOMA AND MPNST
por: Yuan, Ming, et al.
Publicado: (2020)

Oncogenic RABL6A promotes NF1-associated MPNST progression in vivo
por: Kohlmeyer, Jordan L, et al.
Publicado: (2022)

BCRP expression in schwannoma, plexiform neurofibroma and MPNST
por: de Vries, Maurits, et al.
Publicado: (2017)

Spatially- and temporally-controlled postnatal p53 knockdown cooperates with embryonic Schwann cell precursor Nf1 gene loss to promote malignant peripheral nerve sheath tumor formation
por: Hirbe, Angela C., et al.
Publicado: (2016)

Targeting Sporadic and Neurofibromatosis Type 1 (NF1) Related Refractory Malignant Peripheral Nerve Sheath Tumors (MPNST) in a Phase II Study of Everolimus in Combination with Bevacizumab (SARC016)
por: Widemann, Brigitte C., et al.
Publicado: (2019)

Factors Within the Endoneurial Microenvironment Act to Suppress Tumorigenesis of MPNST
por: Stratton, Jo Anne, et al.
Publicado: (2018)

Malignant transformation of plexiform neurofibroma to MPNST while on MEK inhibitor
por: Fasih, Samir, et al.
Publicado: (2021)

PRC2 loss drives MPNST metastasis and matrix remodeling
por: Brockman, Qierra R., et al.
Publicado: (2022)

SHH PATHWAY ACTIVATION IN DEDIFFERENTIATION DURING TUMOR PROGRESSION IN MPNST
por: Yakubov, R Y, et al.
Publicado: (2023)

TYK2 promotes malignant peripheral nerve sheath tumor progression through inhibition of cell death
por: Qin, Wenjing, et al.
Publicado: (2019)

Neoadjuvant Ifosfamide and Epirubicin in the Treatment of Malignant Peripheral Nerve Sheath Tumors
por: Hirbe, Angela C., et al.
Publicado: (2017)

MEK Inhibition Synergizes with TYK2 Inhibitors in NF1-Associated Malignant Peripheral Nerve Sheath Tumors
por: Borcherding, Dana C., et al.
Publicado: (2023)

Knockdown of MSI2 inhibits metastasis by interacting with caveolin-1 and inhibiting its ubiquitylation in human NF1-MPNST cells
por: Yang, Kang, et al.
Publicado: (2020)

Integrative Analysis Identifies Candidate Tumor Microenvironment and Intracellular Signaling Pathways that Define Tumor Heterogeneity in NF1
por: Banerjee, Jineta, et al.
Publicado: (2020)

DNA Methylation and Intra-Clonal Heterogeneity: The Chronic Myeloid Leukemia Model
por: Lebecque, Benjamin, et al.
Publicado: (2021)

Genetic Characterization, Current Model Systems and Prognostic Stratification in PAX Fusion-Negative vs. PAX Fusion-Positive Rhabdomyosarcoma
por: Dehner, Carina A., et al.
Publicado: (2021)

Oncogene Mutation Survey in MPNST Cell Lines Enhances the Dominant Role of Hyperactive Ras in NF1 Associated Pro-Survival and Malignancy
por: Sun, Daochun, et al.
Publicado: (2012)

MEK inhibitors enhance therapeutic response towards ATRA in NF1 associated malignant peripheral nerve sheath tumors (MPNST) in-vitro
por: Fischer-Huchzermeyer, Susan, et al.
Publicado: (2017)

Correction: Knockdown of MSI2 inhibits metastasis by interacting with caveolin-1 and inhibiting its ubiquitylation in human NF1-MPNST cells
por: Yang, Kang, et al.
Publicado: (2020)

Intra-Tumor Genetic Heterogeneity in Wilms Tumor: Clonal Evolution and Clinical Implications
por: Cresswell, George D., et al.
Publicado: (2016)

Conditional Inactivation of Pten with EGFR Overexpression in Schwann Cells Models Sporadic MPNST
por: Keng, Vincent W., et al.
Publicado: (2012)

Genomic Patterns of Malignant Peripheral Nerve Sheath Tumor (MPNST) Evolution Correlate with Clinical Outcome and Are Detectable in Cell-Free DNA
por: Cortes-Ciriano, Isidro, et al.
Publicado: (2023)

How Effective Are Noninvasive Tests for Diagnosing Malignant Peripheral Nerve Sheath Tumors in Patients with Neurofibromatosis Type 1? Diagnosing MPNST in NF1 Patients
por: Schwabe, Maria, et al.
Publicado: (2019)

Monozygotic twins with Neurofibromatosis type 1, concordant phenotype and synchronous development of MPNST and metastasis
por: Melean, German, et al.
Publicado: (2010)

Survivin Expression and Prognostic Significance in Pediatric Malignant Peripheral Nerve Sheath Tumors (MPNST)
por: Alaggio, Rita, et al.
Publicado: (2013)

CK2 blockade causes MPNST cell apoptosis and promotes degradation of β-catenin
por: Kendall, Jed J., et al.
Publicado: (2016)

Combined Mutational and Clonality Analyses Support the Existence of Intra-Tumor Heterogeneity in Papillary Thyroid Cancer
por: Muzza, Marina, et al.
Publicado: (2021)

Plexiform malignant peripheral nerve sheath tumor(MPNST) in infancy and childhood--a case report.
por: Nam, E. S., et al.
Publicado: (1994)

Neurofibromatosis Type 1–Associated MPNST State of the Science: Outlining a Research Agenda for the Future
por: Reilly, Karlyne M., et al.
Publicado: (2017)

Malignant peripheral nerve sheath tumors (MPNST) – Clinicopathological study and treatment outcome of twenty-four cases
por: Kar, Madhabananda, et al.
Publicado: (2006)

HDAC8, A Potential Therapeutic Target for the Treatment of Malignant Peripheral Nerve Sheath Tumors (MPNST)
por: Lopez, Gonzalo, et al.
Publicado: (2015)

Metastatic Malignant Peripheral Nerve Sheath Tumor (MPNST) in Neurofibromatosis Type 1: Challenges in Diagnosis and Management
por: Pulliam, Steven, et al.
Publicado: (2022)

Plexiform neurofibroma of the liver, with malignant transformation to MPNST, in a pediatric patient without neurofibromatosis type 1
por: Ioannou, Maria, et al.
Publicado: (2023)

Hemodynamic Heterogeneity of Reduced Cardiac Reserve Unmasked by Volumetric Exercise Echocardiography
por: Bombardini, Tonino, et al.
Publicado: (2021)

Cell-free DNA ultra-low-pass whole genome sequencing to distinguish malignant peripheral nerve sheath tumor (MPNST) from its benign precursor lesion: A cross-sectional study
por: Szymanski, Jeffrey J., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pd2b146qi4ghqbn1b9n2fpl2le